These eight batches were compared in a double-blind, randomized study in patients undergoing assisted reproductive technology.
In order to compare the hemodynamic efficacy and safety of 6% HES 130/0.4 and NaCl 0.9% for HDS in patients with severe sepsis, we designed a prospective, multicenter, active-controlled, double-blind, randomized study in intensive care units.
In a double-blind, randomized study in 332 outpatients suffering from major depression, the effects of agomelatine 25 50 mg/day and venlafaxine 75 150 mg/day on subjective sleep quality were compared.
Whereas prior work on the RDQ was completed with patients seen in primary care, the current investigation was undertaken in the context of a multicenter, double-blind, randomized study in which Scandinavian patients with heartburn as the predominant symptom were treated with esomeprazole for 2 weeks.
ACCOMPLISH was a double-blind randomized study in which 11,506 patients with hypertension complicated by organ damage or associated with diabetes or overt CV disease were randomized to either benazepril plus amlodipine or benazepril plus hydrochlorothiazide as first-step treatment.
safety and tolerability in terms of calcemic effect has been proven in double-blind randomized study in 101 postmenopausal osteoporotic women, in placebo-controlled phase IIa (119 enrolled subjects) and follow-on phase IIb (514 patients) trial for the treatment of benign prostate hyperplasia (BPH) [ 128, 129].
In a recent, multicenter, double-blind, randomized study, in addition to a standard therapy with antituberculotic drugs, 146 patients with newly diagnosed open tuberculosis of the lung received either 100,000 IU vitamin D3 four times at 14-d intervals or placebo.
Single-blind randomized study of terbinafine vs itraconazole in tinea pedis (two weeks vs four weeks).
A double-blind, randomized, study was conducted in 29 centers in Romania to evaluate the effect of agomelatine 25 50 mg/day (n=144 patients) on general interest, overall clinical efficacy, and functionality in comparison with escitalopram 10 20 mg/day (n=143 patients) in out-patients diagnosed with moderate to severe Major Depressive Disorder (MDD).
Methods: A prospective, double-blind, randomized study was conducted in 120 consecutive patients with SAH (Hunt Hess Scale (HHS) I III).
